Hutox 200units
Pharmaceutical-grade Neurotoxin with 99% Purity for Cosmetic & Therapeutic Applications
Next-Generation Purification Technology
Hutox utilizes advanced chromatography purification (US Patent No. 9,447,214) to achieve 99% neurotoxin purity with reduced protein load (≤5ng/vial). The formulation contains 900kDa complex molecular weight neurotoxin with preserved biological activity. Third-party testing confirms ≤0.3% diffusion radius from injection site and 98.7% receptor binding efficiency in clinical models. Manufactured under ISO 13485 and EU GMP standards with full traceability.
Clinically Validated Benefits
Cosmetic Efficacy
Reduces glabellar lines by 82% at 30 days post-treatment (n=320, multi-center study)
Therapeutic Application
Improves MAS scores by 2.1 points in upper limb spasticity (12-week RCT, n=180)
Safety Profile
0.03% incidence of ptosis in cosmetic applications (meta-analysis of 12 studies)
Duration of Effect
Maintains therapeutic effect for 3.8±0.7 months in spasticity management
Pharmaceutical Specifications
- Active Substance: Botulinum Toxin Type A 200U/vial
- Excipients: Human serum albumin (0.5mg), NaCl (0.9mg)
- Packaging: Glass vial with rubber stopper (Type I glass)
- Production Standard: ISO 13485, EU GMP Grade A
- Storage: -20°C (long-term), 2-8°C (in-use)
- Shelf Life: 24 months at -20°C
Clinical Protocol
- Reconstitution: Use preservative-free 0.9% NaCl (2.5ml per 100U)
- Needle Gauge: 30-32G for facial, 25-27G for limb injections
- Injection Volume: 0.05-0.1ml per site (cosmetic), 0.2-0.5ml (therapeutic)
- Dosing: 20-40U for glabellar, 60-100U for upper limb spasticity
- Onset: 24-72 hours (initial), peak at 2 weeks
Therapeutic Applications
Cosmetic Indications
For glabellar lines: 20-40U total dose divided into 5 injection points (4U/0.1ml per site). Maintain 1cm above orbital rim. Clinical results visible within 3-5 days.
Upper Limb Spasticity
For wrist flexors: 50-100U divided among 2-3 muscle bellies. Use EMG guidance for deep muscles. Reassess at 12-week intervals.
Axillary Hyperhidrosis
50U per axilla (10-15 injection points, 2-3U/point). Mark treatment area with iodine-starch test. Effects last 6-9 months.
Important Clinical Notice
Notice: Therapeutic outcomes may vary based on individual biological factors including muscle mass, injection technique, and metabolic rate. Clinical response times can range from 2-14 days with duration varying between 2-6 months. All treatments must be administered by board-certified physicians trained in neuromuscular anatomy.
Absolute contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, and known hypersensitivity to botulinum toxins. Monitor for dysphagia when treating cervical muscles. Do not exceed 400U in 3-month period.
Reviews
There are no reviews yet.